different glp 1 GLP-1 agonists approved for clinical use. GLP-1 agonists are available Comparing Ozempic, Wegovy and Other

Diabetologia 64 , 25502561 (2021)

Carlos R

This can increase the severity of illness and contribute to additional conditions arising

In SUSTAIN trials, semaglutide had higher rates of GI side effects than dulaglutide, but most were mild to moderate and occurred during dose escalation

*Correspondence: Li Chen, [email protected] This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Systematic rotation of injection sites prevents repeated trauma to the same area